Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for 7 days, with or without INTERCEPT pathogen reduction.
Hervé IsolaCatherine RavanatFloriane RudwillAnais PongerardDelphine HaasAnita EcklyChristian GachetBéatrice HechlerPublished in: Transfusion (2021)
Removal of citrate from PAS-III has a beneficial impact on platelet metabolism, spontaneous activation, and apoptosis, and improves platelet aggregation, irrespective of photochemical treatment, which should allow transfusion of platelets with better and longer-lasting functional properties.